with nearly all subjects developing hepatitis A antibodies (anti-HAV) within 2 weeks. [3] However, a second dose of vaccine, given 6 or 12 to 18 months after the first dose in accordance with the ...

Future Virology. 2012;7(5):461-472. Studies show that the PCR detection of HAV RNA has an important role in the early diagnosis of infection, especially in the window period during outbreaks and ...